Using Engineered Particles in Capsules for Rapid-to-Clinic Dry Powder Inhalation Applications

This webinar covers key considerations for optimizing pulmonary drug delivery and improving speed-to-clinic for dry-powder inhalation (DPI) applications. An API-independent platform capable of aerosol‑independent dose ranging and rapid progression to clinical supplies is described. Formulation, process scale-up, and critical features of specialty capsules appropriate for inhaled delivery of spray-dried powders are reviewed.